A Comparison of Behavioral and Psychological Symptoms of Dementia (BPSD) and BPSD Sub-Syndromes in Early-Onset and Late-Onset Alzheimer's Disease.


Journal

Journal of Alzheimer's disease : JAD
ISSN: 1875-8908
Titre abrégé: J Alzheimers Dis
Pays: Netherlands
ID NLM: 9814863

Informations de publication

Date de publication:
2022
Historique:
pubmed: 6 12 2021
medline: 1 3 2022
entrez: 5 12 2021
Statut: ppublish

Résumé

Behavioral and psychological symptoms of dementia (BPSD) have a large impact on the quality of life of patients with Alzheimer's disease (AD). Few studies have compared BPSD between early-onset (EOAD) and late-onset (LOAD) patients, finding conflicting results. The aims of this study were to: 1) characterize the presence, overall prevalence, and time of occurrence of BPSD in EOAD versus LOAD; 2) estimate the prevalence over time and severity of each BPSD in EOAD versus LOAD in three stages: pre-T0 (before the onset of the disease), T0 (from onset to 5 years), and T1 (from 5 years onwards); 3) track the manifestation of BPSD sub-syndromes (i.e., hyperactivity, psychosis, affective, and apathy) in EOAD versus LOAD at T0 and T1. The sample includes 1,538 LOAD and 387 EOAD diagnosed from 1996 to 2018. Comprehensive assessment batteries, including the Neuropsychiatric Inventory (NPI), were administered at the first medical assessment and at different follow-up period. The overall prevalence for the most of BPSD was significantly higher in EOAD compared to LOAD whereas most BPSD appeared significantly later in EOAD patients. Between the two groups, from pre-T0 to T1 we recorded a different pattern of BPSD prevalence over time as well as for BPSD sub-syndromes at T0 and T1. Results on severity of BPSD did not show significant differences. EOAD and LOAD represent two different forms of a single entity not only from a neuropathological, cognitive, and functional level but also from a psychiatric point of view.

Sections du résumé

BACKGROUND
Behavioral and psychological symptoms of dementia (BPSD) have a large impact on the quality of life of patients with Alzheimer's disease (AD). Few studies have compared BPSD between early-onset (EOAD) and late-onset (LOAD) patients, finding conflicting results.
OBJECTIVE
The aims of this study were to: 1) characterize the presence, overall prevalence, and time of occurrence of BPSD in EOAD versus LOAD; 2) estimate the prevalence over time and severity of each BPSD in EOAD versus LOAD in three stages: pre-T0 (before the onset of the disease), T0 (from onset to 5 years), and T1 (from 5 years onwards); 3) track the manifestation of BPSD sub-syndromes (i.e., hyperactivity, psychosis, affective, and apathy) in EOAD versus LOAD at T0 and T1.
METHODS
The sample includes 1,538 LOAD and 387 EOAD diagnosed from 1996 to 2018. Comprehensive assessment batteries, including the Neuropsychiatric Inventory (NPI), were administered at the first medical assessment and at different follow-up period.
RESULTS
The overall prevalence for the most of BPSD was significantly higher in EOAD compared to LOAD whereas most BPSD appeared significantly later in EOAD patients. Between the two groups, from pre-T0 to T1 we recorded a different pattern of BPSD prevalence over time as well as for BPSD sub-syndromes at T0 and T1. Results on severity of BPSD did not show significant differences.
CONCLUSION
EOAD and LOAD represent two different forms of a single entity not only from a neuropathological, cognitive, and functional level but also from a psychiatric point of view.

Identifiants

pubmed: 34864668
pii: JAD215061
doi: 10.3233/JAD-215061
pmc: PMC8842787
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

691-699

Références

J Psychiatr Res. 1975 Nov;12(3):189-98
pubmed: 1202204
Dement Geriatr Cogn Disord. 1999 Mar-Apr;10(2):130-8
pubmed: 10026387
Gerontologist. 1969 Autumn;9(3):179-86
pubmed: 5349366
Neurology. 1984 Jul;34(7):939-44
pubmed: 6610841
J Alzheimers Dis. 2010;19(4):1401-8
pubmed: 20061618
Neurology. 1993 Nov;43(11):2412-4
pubmed: 8232972
Eur J Neurol. 1996 May;3(3):198-202
pubmed: 21284770
J Geriatr Psychiatry Neurol. 2020 Mar;33(2):73-84
pubmed: 32013737
Cureus. 2016 May 27;8(5):e625
pubmed: 27433404
Psychiatry Clin Neurosci. 2009 Jun;63(3):374-84
pubmed: 19566770
Alzheimers Dement. 2015 Mar;11(3):280-90
pubmed: 25074342
Alzheimer Dis Assoc Disord. 2009 Oct-Dec;23(4):306-14
pubmed: 19568149
Neurobiol Aging. 2013 Aug;34(8):2014-22
pubmed: 23561509
Int J Geriatr Psychiatry. 2019 Sep;34(9):1326-1334
pubmed: 30198597
J Alzheimers Dis. 2014;40(1):221-6
pubmed: 24448780
Am J Alzheimers Dis Other Demen. 2019 Nov-Dec;34(7-8):433-438
pubmed: 30935215
J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1070-4
pubmed: 16024880
Am J Geriatr Psychiatry. 2017 Oct;25(10):1074-1082
pubmed: 28754586
Lancet Neurol. 2011 Sep;10(9):829-43
pubmed: 21778116
Front Aging Neurosci. 2020 Jan 30;12:9
pubmed: 32082139
Acta Clin Belg. 2007 Nov-Dec;62(6):426-32
pubmed: 18351187
Int J Geriatr Psychiatry. 2018 Jan;33(1):47-57
pubmed: 28067961
PLoS One. 2018 May 15;13(5):e0196933
pubmed: 29763448
Brain. 2010 Feb;133(Pt 2):512-28
pubmed: 20080878
J Gerontol A Biol Sci Med Sci. 2003 Jun;58(6):548-54
pubmed: 12807927
Br J Psychiatry. 1982 Jun;140:566-72
pubmed: 7104545
Alzheimers Res Ther. 2017 Aug 31;9(1):70
pubmed: 28859660
Tijdschr Gerontol Geriatr. 2018 Jun;49(3):95-102
pubmed: 29488192
Dement Geriatr Cogn Disord. 2012;34(5-6):319-27
pubmed: 23208452
QJM. 2017 Sep 1;110(9):565-570
pubmed: 28383687
Alzheimers Dement. 2013 Sep;9(5):602-8
pubmed: 23562430
J Am Geriatr Soc. 1996 May;44(5):583-7
pubmed: 8617910
J Affect Disord. 2016 Jan 15;190:264-271
pubmed: 26540080
Alzheimers Res Ther. 2019 May 24;11(1):48
pubmed: 31122267
Neurology. 2015 Feb 10;84(6):617-22
pubmed: 25589671
JAMA Neurol. 2019 Jul 15;:
pubmed: 31305929
J Am Geriatr Soc. 2018 Apr;66 Suppl 1:S4-S12
pubmed: 29659001
Int J Geriatr Psychiatry. 2007 Sep;22(9):896-901
pubmed: 17343292
Dement Neuropsychol. 2008 Oct-Dec;2(4):256-260
pubmed: 29213581
J Am Geriatr Soc. 1983 Dec;31(12):721-7
pubmed: 6418786
J Neurol Sci. 2017 Feb 15;373:295-302
pubmed: 28131209
Geroscience. 2021 Feb;43(1):213-223
pubmed: 33420706
Minerva Med. 2021 Aug;112(4):456-466
pubmed: 34056888
Alzheimers Dement. 2011 Sep;7(5):532-9
pubmed: 21889116
J Alzheimers Dis. 2017;56(3):929-938
pubmed: 28059789
Neurology. 1994 Dec;44(12):2308-14
pubmed: 7991117
Can J Diabetes. 2017 Feb;41(1):114-119
pubmed: 27614804
Int Psychogeriatr. 2018 Jan;30(1):103-113
pubmed: 28927477
Int J Geriatr Psychiatry. 2018 May 30;:
pubmed: 29851148
Am J Geriatr Psychiatry. 2005 Jun;13(6):469-74
pubmed: 15956266
Neurologia (Engl Ed). 2018 May;33(4):244-253
pubmed: 26546285
Am J Alzheimers Dis Other Demen. 2018 Mar;33(2):93-99
pubmed: 29210282
Dement Geriatr Cogn Disord. 2008;25(1):1-8
pubmed: 18025783
Neurobiol Aging. 2020 Jan;85:74-82
pubmed: 31735378
Int J Geriatr Psychiatry. 2009 Apr;24(4):341-6
pubmed: 18814198
Alzheimers Dement. 2011 May;7(3):263-9
pubmed: 21514250
Curr Opin Behav Sci. 2018 Aug;22:7-13
pubmed: 30123816
J Alzheimers Dis. 2016 May 11;53(2):403-17
pubmed: 27176075
Front Neurol. 2012 May 07;3:73
pubmed: 22586419

Auteurs

Natalia Altomari (N)

Department of Mathematics and Computer Science, University of Calabria, Rende (CS), Italy.

Francesco Bruno (F)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Valentina Laganà (V)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Nicoletta Smirne (N)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Rosanna Colao (R)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Sabrina Curcio (S)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Raffaele Di Lorenzo (R)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Francesca Frangipane (F)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Raffaele Maletta (R)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Gianfranco Puccio (G)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Amalia Cecilia Bruni (AC)

Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Lamezia Terme (CZ), Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH